About Four and a half LIM domains protein 1
Four and a half LIM domains protein 1 (FHL1) is a protein
from Homo sapiens identified by UniProt accession
Q13642, 323 residues long.
MolForge cross-references it against 0 known binders and
198 disease associations.
Target properties
| Protein name | Four and a half LIM domains protein 1 |
| UniProt accession | Q13642 |
| Gene | FHL1 |
| Organism | Homo sapiens |
| Length | 323 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (198)
Diseases linked to this target (Open Targets).
- X-linked myopathy with postural muscle atrophy · score 0.80
- myopathy · score 0.69
- reducing body myopathy · score 0.62
- Uruguay Faciocardiomusculoskeletal syndrome · score 0.56
- Emery-Dreifuss muscular dystrophy · score 0.55
- Abnormality of the cardiovascular system · score 0.51
- X-linked Emery-Dreifuss muscular dystrophy · score 0.46
- Myocardial Ischemia · score 0.39
- Abnormality of the musculature · score 0.33
- Crohn's disease · score 0.32
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13642-F1 | alphafold | PREDICTED | 72.61 | — |
Amino-acid sequence (323 residues)
MAEKFDCHYC RDPLQGKKYV QKDGHHCCLK CFDKFCANTC VECRKPIGAD SKEVHYKNRF WHDTCFRCAK CLHPLANETF VAKDNKILCN KCTTREDSPK CKGCFKAIVA GDQNVEYKGT VWHKDCFTCS NCKQVIGTGS FFPKGEDFYC VTCHETKFAK HCVKCNKAIT SGGITYQDQP WHADCFVCVT CSKKLAGQRF TAVEDQYYCV DCYKNFVAKK CAGCKNPITG KRTVSRVSHP VSKARKPPVC HGKRLPLTLF PSANLRGRHP GGERTCPSWV VVLYRKNRSL AAPRGPGLVK APVWWPMKDN PGTTTASTAK NAP
Explore Four and a half LIM domains protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets